Results 211 to 220 of about 240,995 (321)

Effect of early use of ivabradine on left ventricular remodeling after primary percutaneous coronary intervention in patients with acute ST‐segment elevation myocardial infarction: A pilot test [PDF]

, 2020
Yan Xu, Wenying Zhang, Xinbo Zhong, Shaodi Yan, Haijun Chen, Ruirui Guo, Xinlin Luo, Qiang Liu   +7 more
openalex   +1 more source

Pharmacological inhibition of hydroxysteroid 11‐beta dehydrogenase type 1 (11‐βHSD1) after myocardial infarction preserves cardiac function in a translational mini‐pig model

British Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Plasma glucocorticoids increase acutely after MI, thereafter tissue levels are amplified selectively within cells expressing 11‐ßhydroxysteroid dehydrogenase type 1 (11‐ßHSD1) that regenerates active glucocorticoids from circulating metabolites.
Sara Al Disi, Raimondo Ascione, Shazia Khan, Thomas Johnson, Eva Sammut, Vito Domenico Bruno, Daniel Baz Lopez, Carol‐Anne James, Joanna Simpson, Natalie Z. Homer, Michael Millar, Trisha Singh, Alex von Kreigsheim, Nick L. Mills, Brian R. Walker, Ruth Andrew, Scott P. Webster, Andrew Whittaker, Adrian Freeman, Gillian A. Gray   +19 more
wiley   +1 more source

Side branch predilatation during percutaneous coronary bifurcation intervention: Long-term mortality analysis

Dobrin Vassilev, Niya Mileva, Panayot Panayotov, Pavel Nikolov, Liubomir Dosev, Kiril Karamfiloff, Gianluca Rigatelli, Robert Gil, Goran Stanković, Yves Louvard   +9 more
openalex   +2 more sources

P1746Comparison of influencing factors on platelet reactivity in various platelet function test after percutaneous coronary interventions [PDF]

, 2017
S. Y. Choi, M.H. Kim, S.J. Kim, K.M. Lee, James Park, Victor L. Serebruany   +5 more
openalex   +1 more source

Cardiovascular Health in Women—Across the Lifespan

Clinical Endocrinology, EarlyView.
ABSTRACT Cardiovascular disease (CVD) remains the leading cause of mortality and morbidity among women worldwide. However, CVD continues to be perceived as a predominantly male issue. CVD in women therefore remains understudied, underrecognized and undertreated.
Jaya Chandrasekhar, Jessica Yao, Simone Gong, Madhuka Wijayarathne, Monique Watts, Swati Mukherjee   +5 more
wiley   +1 more source

Coronary Artery Vasculitis: A Nightmare Complicating Percutaneous Coronary Intervention. [PDF]

JACC Case Rep
Zhang T, Du J, Zhang H, Zhang X, Qiao B, Chen T, Zhou Y, Xu L, Pan L, Du Y.   +9 more
europepmc   +1 more source

Improving cardiovascular risk stratification through the derivation and validation of an elevated triglyceride‐glucose index

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Background and Aims Triglyceride‐glucose (TyG) index, is an emerging prognostic biomarker in atherosclerotic cardiovascular disease (ASCVD). Validation of its clinical value and of clinically relevant prognostic cut‐off, remains an unmet need to integrate TyG into primary prevention protocols.
Georgios Mavraganis, Georgios Georgiopoulos, Stavros Athanasopoulos, Dimitrios Terentes‐Printzios, Georgios Zervas, Christina Konstantaki, Maria Eleni Koilakou, Sofia‐Panagiota Giannakopoulou, Maria‐Angeliki Dimopoulou, Christina Chrysochoou, Konstantinos Tsioufis, Christos Pitsavos, Evangelos Liberopoulos, Konstantinos Stellos, Charalambos Vlachopoulos, Demosthenes Panagiotakos, Kimon Stamatelopoulos   +16 more
wiley   +1 more source

Psoas muscle index as a predictor of mortality following percutaneous coronary intervention. [PDF]

J Geriatr Cardiol
Hopkins S, Bhagat S, Zawadzki J, Pollack I, Fowler J, Toma C, Ibrahim J, Wolfe JD, Hickey GW.   +8 more
europepmc   +1 more source

Effect of statin on long-term outcomes in persistent tobacco users receiving percutaneous coronary intervention: A longitudinal, retrospective cohort study

Mao-Jen Lin, Hau-De Lin, Chuan-Zhong Cai, Ming-Jen Chuang, Feng-Ching Yang, Kuo Feng Chiang, Han‐Ping Wu   +6 more
openalex   +1 more source

Age disparities in SGLT2 inhibitor prescription among people with type 2 diabetes: The role of frailty and sex

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Background Older adults with type 2 diabetes (T2DM) are less likely to receive sodium–glucose cotransporter‐2 (SGLT2) inhibitors, despite their proven cardio‐renal benefits and safety. Whether this age‐related gap is driven by frailty, sex, or other factors remains unclear.
Changyuan Yang, Petra Denig, Lynne Chepulis, Ryan G. Paul, Jung‐Im Shin, Ron T. Gansevoort, Priya Vart   +6 more
wiley   +1 more source